Results 181 to 190 of about 3,913,962 (299)

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Analysis of queries to a Swedish drug information centre identifies scientific knowledge gaps. [PDF]

Sci Rep
Nilsson J, Kindblom JM, Izsak J.
europepmc   +1 more source

Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital. [PDF]

Sci Rep, 2022
Heck J, Stichtenoth DO, Sabau R, Schröder C, Engeli S, Pape T, O'Connell N, Schumacher C, Krause O, Koop F.   +9 more
europepmc   +1 more source

Drug information

Australian Prescriber, 2008
openaire   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Perceptions of Clients on a University-based Drug Information Service affecting Medication Safety. [PDF]

Acta Med Philipp
Ngo FLU, Garcia KES, Loquias MM, Robles YR, Capule FR.   +4 more
europepmc   +1 more source

Use of Nonprescription and Prescription Drugs and Drug Information Sources among Breastfeeding Women in Japan: A Cross-Sectional Study. [PDF]

Int J Environ Res Public Health, 2022
Fujii Y, Hirokawa K, Kobuke Y, Kubota T, Yoshitake T, Haraguchi K, Honda Y, Kobayashi H, Harada KH.   +8 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

The incentivized drug information services among community pharmacists: a multi-centre cross-sectional study in Indonesia. [PDF]

Prim Health Care Res Dev
Bahar MA, Kausar MN, Khairunnisa K, Pradipta IS.   +3 more
europepmc   +1 more source

Evaluation of adverse drug reaction formatting in drug information mobile phone applications. [PDF]

J Med Libr Assoc, 2022
McConachie SM, Berri D, Konja J, Giuliano CA.   +3 more
europepmc   +1 more source